Loculated pleural effusion is a condition in which fluid accumulates in the pleural space, the area between the lungs and the chest wall, and becomes trapped in pockets or loculations. This condition is often seen in patients who have had a history of chest trauma or surgery, and can cause respiratory distress and a decrease in lung function. It can also be caused by an infection or an underlying medical condition. Doctors are still trying to unlock the mystery of loculated pleural effusion in order to better diagnose and treat it.
The causes of loculated pleural effusion can be divided into two categories: primary and secondary causes. Primary causes are those that are directly related to the formation of the loculations, such as chest trauma or surgery. Secondary causes are those that cause the fluid to accumulate in the pleural space, such as an infection or an underlying medical condition.
The diagnosis of loculated pleural effusion is often challenging for doctors. Chest X-rays, computed tomography (CT) scans, and ultrasound are all commonly used to diagnose the condition. Chest X-rays can show the presence of fluid in the pleural space, but they are not very accurate in determining the size and shape of the loculations. CT scans are more accurate in determining the size and shape of the loculations, but they are not always available. Ultrasound can also be used to diagnose loculated pleural effusion, but it is not as accurate as CT scans.
The treatment of loculated pleural effusion depends on the underlying cause. If the cause is chest trauma or surgery, the fluid may need to be drained to relieve pressure on the lungs. This is done using a needle or a catheter. If the cause is an infection, antibiotics may be prescribed to treat the infection. If the cause is an underlying medical condition, treatment of the condition may be necessary.
Loculated pleural effusion can lead to a number of complications, including respiratory distress, decreased lung function, and an increased risk of infection. It can also cause pain and discomfort in the chest area. If left untreated, loculated pleural effusion can lead to serious complications, such as lung collapse and atelectasis.
Loculated pleural effusion is a condition in which fluid accumulates in the pleural space and becomes trapped in pockets or loculations. It can be caused by chest trauma or surgery, an infection, or an underlying medical condition. Diagnosis of the condition can be challenging for doctors, and treatment depends on the underlying cause. Loculated pleural effusion can lead to a number of complications, including respiratory distress, decreased lung function, and an increased risk of infection. Doctors are still trying to unlock the mystery of loculated pleural effusion in order to better diagnose and treat it.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation